Managing diabetes-related costs and quality of life issues: Value of insulin analogs and pens for inpatient use-Reference-Cited by-同舟云学术

Managing diabetes-related costs and quality of life issues: Value of insulin analogs and pens for inpatient use

Published:2010-08 Issue:3 Volume:96 Page:191-199
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Cornell Susan

Publisher

Elsevier BV

Subject

Health Policy

Reference78 articles.

1. National Changing Diabetes Program. Study finds cost of diabetes in the United States exceeds $218 billion, http://www.ncdp.com/downloads/pressReleases/NCDP%20Economic%20Barometer%20FINAL.pdf; 2008.

2. Economic costs of diabetes in the U.S. in 2007;American Diabetes Association;Diabetes Care,2008

3. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes;Umpierrez;Journal of Clinical Endocrinology and Metabolism,2002

4. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project;Furnary;Endocrine Practice,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision Dosing of Rapid-Acting Insulin Matters;Diabetes Technology & Therapeutics;2020-05-01

2. Randomized controlled evaluation of an insulin pen storage policy;American Journal of Health-System Pharmacy;2017-12-15

3. Examining Factors That Impact Inpatient Management of Diabetes and the Role of Insulin Pen Devices;Canadian Journal of Diabetes;2017-02

4. Determinants of nurse satisfaction using insulin pen devices with safety needles: an exploratory factor analysis;Clinical Diabetes and Endocrinology;2015-11-09

5. Current World Literature;Current Opinion in Cardiology;2011-07